CIK 0001412408
- Large accelerated filer
Phreesia, Inc.
Sign in to watch- Ticker
- PHR
- Exchange
- NYSE
- Industry
- Services-Business Services, NEC
- FY end
- Jan 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 888-654-7473
- Business address
- 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803
- Former names
- Phreesia Inc
- Open-market buys, last 90 days
- $683
- in 1 filing
- Open-market sales, last 90 days
- $67,153
- in 1 filing, $67K under 10b5-1 plans
Net −$66,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | Gandhi Balaji Chief Financial Officer | Sale | −1,827 | $27.46 | $50K | 103,591 |
| 2025-03-19 | Linetsky David SVP, Life Sciences | Sale | −81 | $27.85 | $2K | 8,731 |
| 2025-03-19 | Linetsky David SVP, Life Sciences | Sale | −7 | $28.31 | $198 | 8,724 |
| 2025-03-18 | Linetsky David SVP, Life Sciences | Sale | −39 | $26.95 | $1K | 8,812 |
| 2025-03-17 | Hoffman Allison C General Counsel & Secretary | Sale 10b5-1 | −3,496 | $25.32 | $89K | 139,134 |
| 2025-02-19 | Roberts Evan Chief Operating Officer | Sale 10b5-1 | −177 | $30.00 | $5K | 741,020 |
| 2025-02-19 | Gandhi Balaji Chief Financial Officer | Sale 10b5-1 | −96 | $30.00 | $3K | 105,418 |
| 2025-02-18 | Roberts Evan Chief Operating Officer | Sale 10b5-1 | −3,519 | $30.06 | $106K | 741,197 |
| 2025-02-18 | Gandhi Balaji Chief Financial Officer | Sale 10b5-1 | −5,771 | $30.04 | $173K | 105,514 |
| 2025-02-18 | Hoffman Allison C General Counsel & Secretary | Sale 10b5-1 | −3,496 | $29.72 | $104K | 142,630 |
| 2025-02-14 | Roberts Evan Chief Operating Officer | Sale 10b5-1 | −3,586 | $30.13 | $108K | 744,716 |
| 2025-02-14 | Gandhi Balaji Chief Financial Officer | Sale 10b5-1 | −4,889 | $30.09 | $147K | 111,285 |
| 2025-02-13 | Roberts Evan Chief Operating Officer | Sale 10b5-1 | −16,005 | $30.00 | $480K | 748,302 |
| 2025-02-13 | Gandhi Balaji Chief Financial Officer | Sale 10b5-1 | −28,759 | $30.00 | $863K | 116,174 |
| 2025-02-13 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −11,616 | $29.70 | $345K | 218,135 |
| 2025-02-07 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −300 | $29.52 | $9K | 229,751 |
| 2025-02-05 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −720 | $29.50 | $21K | 230,051 |
| 2025-01-31 | Munson Gillian Director | Grant or award | +351 | $28.46 | $10K | 37,074 |
| 2023-12-18 | Linetsky David SVP, Life Sciences | Sale | −100 | $23.15 | $2K | 9,904 |
| 2022-12-15 | Linetsky David SVP, Life Sciences | Sale | −22 | $34.01 | $748 | 9,770 |
Page 14 of 15 · 283 trades